{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:31:49Z","timestamp":1767054709375,"version":"3.48.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02268-4","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:24:25Z","timestamp":1763979865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of ITGA3 expression in predicting liver metastasis in patients with epithelial ovarian cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Kai","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"2268_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031845","author":"V Tavares","year":"2024","unstructured":"Tavares V, Marques IS, Melo IG, Assis J, Pereira D, Medeiros R. Paradigm shift: a comprehensive review of ovarian cancer management in an era of advancements. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25031845.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2268_CR2","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/0929866530666230607104453","volume":"30","author":"SAM Sherazi","year":"2023","unstructured":"Sherazi SAM, Rafique F, Haris M, Arshad A, Qaiser H, Uzair M, et al. Applications of CRISPR Cas-9 in ovarian cancer research. Protein Peptide Lett. 2023;30(8):653\u201367.","journal-title":"Protein Peptide Lett"},{"key":"2268_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102983","volume":"79","author":"YF Wei","year":"2025","unstructured":"Wei YF, Ning L, Xu YL, Ma J, Li DR, Feng ZF, et al. Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017. EClinicalMedicine. 2025;79:102983.","journal-title":"EClinicalMedicine"},{"key":"2268_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59071183","author":"C Arnaoutoglou","year":"2023","unstructured":"Arnaoutoglou C, Dampala K, Anthoulakis C, Papanikolaou EG, Tentas I, Dragoutsos G, et al. Epithelial ovarian cancer: a five year review. Medicina (B Aires). 2023. https:\/\/doi.org\/10.3390\/medicina59071183.","journal-title":"Medicina (B Aires)"},{"issue":"16","key":"2268_CR5","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.7150\/jca.40590","volume":"11","author":"I Hussain","year":"2020","unstructured":"Hussain I, Xu J, Deng K, Noor Ul A, Wang C, Huang Y, et al. The prevalence and associated factors for liver metastases, development and prognosis in newly diagnosed epithelial ovarian cancer: a large population-based study from the SEER database. J Cancer. 2020;11(16):4861\u20139.","journal-title":"J Cancer"},{"issue":"3","key":"2268_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ygyno.2018.06.022","volume":"150","author":"K Deng","year":"2018","unstructured":"Deng K, Yang C, Tan Q, Song W, Lu M, Zhao W, et al. Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients. Gynecol Oncol. 2018;150(3):460\u20135.","journal-title":"Gynecol Oncol"},{"issue":"12","key":"2268_CR7","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/jog.15809","volume":"49","author":"F Cheng","year":"2023","unstructured":"Cheng F, Wang J, Chen Q, Zhu J. Pulmonary metastasectomy for recurrent metastatic ovarian cancer. J Obstet Gynaecol Res. 2023;49(12):2905\u20139.","journal-title":"J Obstet Gynaecol Res"},{"key":"2268_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020;371:m3773.","journal-title":"BMJ"},{"key":"2268_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8501819","volume":"2022","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Wang R, Luo M, Zhang Y, Guo F, Bai G, et al. JingZhao: a machine learning approach using XGBoost predicts lung metastasis in patients with ovarian cancer. Biomed Res Int. 2022;2022:8501819.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2268_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"X Pang","year":"2023","unstructured":"Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, et al. Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduct Target Ther. 2023;8(1):1.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2268_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jjco\/hyac148","volume":"53","author":"Y Matsumoto","year":"2023","unstructured":"Matsumoto Y, Kage H, Morota M, Zokumasu K, Ando T, Maemura K, et al. Integrin alpha 2 is associated with tumor progression and postoperative recurrence in non-small cell lung cancer. Jpn J Clin Oncol. 2023;53(1):63\u201373.","journal-title":"Jpn J Clin Oncol"},{"issue":"13","key":"2268_CR12","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.7150\/ijbs.72367","volume":"18","author":"Z Peng","year":"2022","unstructured":"Peng Z, Hao M, Tong H, Yang H, Huang B, Zhang Z, et al. The interactions between integrin alpha(5)beta(1) of liver cancer cells and fibronectin of fibroblasts promote tumor growth and angiogenesis. Int J Biol Sci. 2022;18(13):5019\u201337.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"2268_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1053\/j.gastro.2019.10.038","volume":"158","author":"M Liu","year":"2020","unstructured":"Liu M, Zhang Y, Yang J, Cui X, Zhou Z, Zhan H, et al. ZIP4 increases expression of transcription factor ZEB1 to promote integrin alpha3beta1 signaling and inhibit expression of the gemcitabine transporter ENT1 in pancreatic cancer cells. Gastroenterology. 2020;158(3):679\u201392. e671.","journal-title":"Gastroenterology"},{"issue":"1","key":"2268_CR14","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1515\/med-2022-0606","volume":"17","author":"F Hu","year":"2022","unstructured":"Hu F, Zhao L, Wang Y, Ye H, Tang H, Zhou J. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer. Open Med. 2022;17(1):1935\u201343.","journal-title":"Open Med"},{"key":"2268_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00705","volume":"11","author":"A Wu","year":"2020","unstructured":"Wu A, Zhang S, Liu J, Huang Y, Deng W, Shu G, et al. Integrated analysis of prognostic and immune associated integrin family in ovarian cancer. Front Genet. 2020;11:705.","journal-title":"Front Genet"},{"key":"2268_CR16","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2025024","author":"Z Yin","year":"2025","unstructured":"Yin Z, Ma J, Adu-Amankwaah J, Xie G, Wang Y, Tai W, et al. Exosomal integrin alpha 3 promotes epithelial ovarian cancer cell migration via the S100A7\/p-ERK signaling pathway. Acta Biochim Biophys Sin. 2025. https:\/\/doi.org\/10.3724\/abbs.2025024.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"3","key":"2268_CR17","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.bbrc.2018.05.062","volume":"501","author":"KD Sa","year":"2018","unstructured":"Sa KD, Zhang X, Li XF, Gu ZP, Yang AG, Zhang R, et al. A miR-124\/ITGA3 axis contributes to colorectal cancer metastasis by regulating anoikis susceptibility. Biochem Biophys Res Commun. 2018;501(3):758\u201364.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2268_CR18","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/cas.13298","volume":"108","author":"K Koshizuka","year":"2017","unstructured":"Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A, et al. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer. Cancer Sci. 2017;108(8):1681\u201392.","journal-title":"Cancer Sci"},{"issue":"2","key":"2268_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP. Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res. 2025;37(2):289\u201392.","journal-title":"Chin J Cancer Res"},{"key":"2268_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"key":"2268_CR21","doi-asserted-by":"crossref","unstructured":"Saini P, Mirji G, Islam SMS, Simons LM, Bhat SA, Bonfanti AP, et al. Targeting Siglec-10\/alpha3beta1 Integrin Interactions Enhances Macrophage-Mediated Phagocytosis of Pancreatic Cancer. bioRxiv. 2025.","DOI":"10.1101\/2025.05.06.652455"},{"key":"2268_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-3-030-59038-3_15","volume":"1296","author":"K Wang","year":"2020","unstructured":"Wang K, He H. Pancreatic tumor microenvironment. Adv Exp Med Biol. 2020;1296:243\u201357.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2268_CR23","doi-asserted-by":"publisher","first-page":"e24236","DOI":"10.1016\/j.heliyon.2024.e24236","volume":"10","author":"J Gui","year":"2024","unstructured":"Gui J, Yang L, Liu J, Li Y, Zou M, Sun C, et al. Identifying the prognosis implication, immunotherapy response prediction value, and potential targeted compound inhibitors of integrin subunit alpha3 (ITGA3) in human cancers. Heliyon. 2024;10(2):e24236.","journal-title":"Heliyon"},{"issue":"1","key":"2268_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43282-3","volume":"14","author":"TT Gong","year":"2023","unstructured":"Gong TT, Guo S, Liu FH, Huo YL, Zhang M, Yan S, et al. Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes. Nat Commun. 2023;14(1):7802.","journal-title":"Nat Commun"},{"issue":"1","key":"2268_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/ijgc-00009577-200501000-00005","volume":"15","author":"V Loizzi","year":"2005","unstructured":"Loizzi V, Rossi C, Cormio G, Cazzolla A, Altomare D, Selvaggi L. Clinical features of hepatic metastasis in patients with ovarian cancer. Int J Gynecol Cancer. 2005;15(1):26\u201331.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"2268_CR26","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2024.14658","volume":"28","author":"E Uchikura","year":"2024","unstructured":"Uchikura E, Fukuda T, Sengiku T, Noda T, Awazu Y, Wada T, et al. Role of Fyn expression in predicting the sensitivity to platinum\u2013based chemotherapy in patients with ovarian serous carcinoma. Oncol Lett. 2024;28(5):525.","journal-title":"Oncol Lett"},{"issue":"1","key":"2268_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75770-x","volume":"14","author":"W Tan","year":"2024","unstructured":"Tan W, Chen G, Ci Q, Deng Z, Gu R, Yang D, et al. Elevated ITGA3 expression serves as a novel prognostic biomarker and regulates tumor progression in cervical cancer. Sci Rep. 2024;14(1):27063.","journal-title":"Sci Rep"},{"key":"2268_CR28","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.926800","volume":"26","author":"C Feng","year":"2020","unstructured":"Feng C, Jin X, Han Y, Guo R, Zou J, Li Y, et al. Expression and prognostic analyses of ITGA3, ITGA5, and ITGA6 in head and neck squamous cell carcinoma. Med Sci Monit. 2020;26:e926800.","journal-title":"Med Sci Monit"},{"issue":"4","key":"2268_CR29","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.21037\/tlcr-19-633","volume":"9","author":"Q Li","year":"2020","unstructured":"Li Q, Ma W, Chen S, Tian EC, Wei S, Fan RR, et al. High integrin alpha3 expression is associated with poor prognosis in patients with non-small cell lung cancer. Transl Lung Cancer Res. 2020;9(4):1361\u201378.","journal-title":"Transl Lung Cancer Res"},{"issue":"10","key":"2268_CR30","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1111\/cas.14566","volume":"111","author":"FY Ke","year":"2020","unstructured":"Ke FY, Chen WY, Lin MC, Hwang YC, Kuo KT, Wu HC. Novel monoclonal antibody against integrin alpha3 shows therapeutic potential for ovarian cancer. Cancer Sci. 2020;111(10):3478\u201392.","journal-title":"Cancer Sci"},{"issue":"2","key":"2268_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41417-024-00864-7","volume":"32","author":"R Li","year":"2025","unstructured":"Li R, Ji Q, Fu S, Gu J, Liu D, Wang L, et al. ITGA3 promotes pancreatic cancer progression through HIF1alpha- and c-Myc-driven Glycolysis in a collagen I-dependent autocrine manner. Cancer Gene Ther. 2025;32(2):240\u201353.","journal-title":"Cancer Gene Ther"},{"key":"2268_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.614955","volume":"11","author":"G Zhang","year":"2021","unstructured":"Zhang G, Li B, Lin Y. Evaluation of ITGA3 as a biomarker of progression and recurrence in papillary thyroid carcinoma. Front Oncol. 2021;11:614955.","journal-title":"Front Oncol"},{"issue":"6","key":"2268_CR33","doi-asserted-by":"publisher","first-page":"167844","DOI":"10.1016\/j.bbadis.2025.167844","volume":"1871","author":"H Liu","year":"2025","unstructured":"Liu H, Hamaia SW, Dobson L, Weng J, Hernandez FL, Beaudoin CA, et al The voltage-gated sodium channel beta3 subunit modulates C6 glioma cell motility independently of channel activity. Biochim Biophys Acta Mol Basis Dis. 2025;1871(6):167844.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2268_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cancergen.2025.09.003","volume":"298\u2013299","author":"GY Kwon","year":"2025","unstructured":"Kwon GY, Lee S, Hong J, Kim Y, Choi HJ, Yun J, et al. A pilot study of evaluation of a deep-learning-based homologous recombination deficiency assay in Korean patients with ovarian high-grade serous carcinoma: diagnostic performance and clinical implications. Cancer Genet. 2025;298\u2013299:69\u201377.","journal-title":"Cancer Genet"},{"key":"2268_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2024.12.005","volume":"292\u2013293","author":"D Shen","year":"2025","unstructured":"Shen D, Wu C, Chen M, Zhou Z, Li H, Tong X, et al. Prognosis prediction and drug guidance of ovarian serous cystadenocarcinoma through mitochondria gene-based model. Cancer Genet. 2025;292\u2013293:1\u201313.","journal-title":"Cancer Genet"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02268-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02268-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02268-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:27:00Z","timestamp":1767054420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-025-02268-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2268"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02268-4","relation":{},"ISSN":["1755-8794"],"issn-type":[{"type":"electronic","value":"1755-8794"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the ethical principles of the World Medical Association Declaration of Helsinki, relevant clinical research regulations, and the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) network guidelines. The study protocol was approved by the Ethics Committee of Puren Hospital Affiliated to Wuhan University of Science and Technology(Ethical Approval Number: CRWG2024R020). Written informed consent to participate has been obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}